Decreased SARS-CoV-2 viral load following vaccination

Cited by (510)

Items 101–200 of 510

1. SARS-CoV-2 Vaccines: Where Are We Now?
   Katie L. Flanagan, Chandini Raina MacIntyre, Peter Bruce McIntyre, Michael R. Nelson · 2021 · The Journal of Allergy and Clinical Immunology In Practice
2. A comparative overview of SARS‑CoV‑2 and its variants of concern
   Aqeel Ahmad, Mohammed Ali Mullah Fawaz, Arafeen Aisha · 2022 · Infezioni in Medicina
3. The dynamic relationship between COVID-19 cases and SARS-CoV-2 wastewater concentrations across time and space: Considerations for model training data sets
   Rebecca Schill, Kara L. Nelson, Sasha Harris-Lovett, Rose S. Kantor · 2023 · The Science of The Total Environment
4. Polyethylene glycol: Properties, applications, and challenges
   Sherif A. Gaballa, Youssef Wahib Naguib, Fatma Mohammed Mady, Khaled Khaled · 2023 · Journal of advanced Biomedical and Pharmaceutical Sciences
5. Vaccine Passports Done Equitably
   Ryan Tanner, Colleen M. Flood · 2021 · JAMA Health Forum
6. Will vaccine-derived protective immunity curtail COVID-19 variants in the US?
   Marina Mancuso, Steffen E. Eikenberry, Abba B. Gumel · 2021 · Infectious Disease Modelling
7. Risk of Vaccine Breakthrough SARS-CoV-2 Infection and Associated Factors in Healthcare Workers of Trieste Teaching Hospitals (North-Eastern Italy)
   Paolo Basso, Corrado Negro, Luca Cegolon, Francesca Larese Filon · 2022 · Viruses
8. COVID-19 vaccination passport: prospects, scientific feasibility, and ethical concerns
   Khan Sharun, Ruchi Tiwari, Kuldeep Dhama, Ali Ahmed Rabaan, Saad Alhumaid · 2021 · Human Vaccines & Immunotherapeutics
9. Design of control strategies to help prevent the spread of COVID-19 pandemic
   Seyyed‐Mahdi Hosseini‐Motlagh, Mohammad Reza Ghatreh Samani, Shamim Homaei · 2021 · European Journal of Operational Research
10. Differences in Transmission between SARS-CoV-2 Alpha (B.1.1.7) and Delta (B.1.617.2) Variants
    Camino Trobajo‐Sanmartín, Iván Martínez‐Baz, Ana Miqueleiz, Miguel Fernández-Huerta, Cristina Burgui, Itziar Casado, Fernando Baigorría, Ana Navascués, Jesús Castilla, Carmen Ezpeleta · 2022 · Microbiology Spectrum
11. SARS-CoV-2 viral load is associated with risk of transmission to household and community contacts
    Darlene Bhavnani, Emily R. James, Kaitlyn E. Johnson, Sylvie Beaudenon‐Huibregtse, Patrick Chang, Paul J. Rathouz, Minda Weldon, Andreas T. Matouschek, Amy E. Young · 2022 · BMC Infectious Diseases
12. Full protection from SARS-CoV-2 brain infection and damage in susceptible transgenic mice conferred by MVA-CoV2-S vaccine candidate
    Javier Villadiego, Juan García‐Arriaza, Reposo Ramírez‐Lorca, Roberto García‐Swinburn, Daniel Cabello-Rivera, Alicia E. Rosales‐Nieves, María I. Álvarez-Vergara, Fernando Cala-Fernández, Ernesto García‐Roldán, Juan L. López-Ogáyar et al. · 2023 · Nature Neuroscience
13. Characterisation of Omicron Variant during COVID-19 Pandemic and the Impact of Vaccination, Transmission Rate, Mortality, and Reinfection in South Africa, Germany, and Brazil
    Carolina Ribeiro Xavier, Rafael Sachetto Oliveira, Vinícius da Fonseca Vieira, Marcelo Lobosco, Rodrigo Weber dos Santos · 2022 · BioTech
14. The Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) mRNA Vaccine-Breakthrough Infection Phenotype Includes Significant Symptoms, Live Virus Shedding, and Viral Genetic Diversity
    Simon D. Pollett, Stephanie A Richard, Anthony C Fries, Mark P. Simons, Katrin Mende, Tahaniyat Lalani, Tida Lee, Sharon Chi, Rupal M. Mody, Cristian Madar et al. · 2021 · Clinical Infectious Diseases
15. Stock market volatility and the COVID-19 reproductive number
    Fernando Díaz, Pablo A. Henríquez, Diego Winkelried · 2021 · Research in International Business and Finance
16. Comparative Effectiveness of Coronavirus Vaccine in Preventing Breakthrough Infections among Vaccinated Persons Infected with Delta and Alpha Variants
    Irina Kislaya, Eduardo Freire Rodrigues, Vítor Borges, João Paulo Gomes, Carlos Sousa, José Pedro Almeida, André Peralta‐Santos, Baltazar Nunes, PT-COVID-19 Group2 · 2021 · Emerging infectious diseases
17. Targeting SARS-CoV-2 receptor-binding domain to cells expressing CD40 improves protection to infection in convalescent macaques
    R. Marlin, V. Godot, Sylvain Cardinaud, Mathilde Galhaut, Séverin Coléon, S. Zurawski, N. Dereuddre-Bosquet, M. Cavarelli, Anne-Sophie Gallouët, P. Maisonnasse et al. · 2021 · Nature Communications
18. Population immunity and vaccine protection against infection
    Eyal Leshem, Benjamin Alan Lopman · 2021 · The Lancet
19. Vaccine‐induced binding and neutralizing antibodies against Omicron 6 months after a homologous BNT162b2 booster
    Julien Favresse, Constant Gillot, Jean‐Louis Bayart, Clara David, Germain Simon, Loris Wauthier, Mélanie Closset, Jean‐Michel Dogné, Jonathan Douxfils · 2022 · Journal of Medical Virology
20. AGA Rapid Review and Guideline for SARS-CoV2 Testing and Endoscopy Post-Vaccination: 2021 Update
    Shahnaz Sultan, Shazia Mehmood Siddique, Siddharth Singh, Osama Altayar, Angela M. Caliendo, Perica Davitkov, Joseph D. Feuerstein, Vivek Kaul, Joseph K. Lim, Reem A. Mustafa et al. · 2021 · Gastroenterology
21. Vaccines and variants: Modelling insights into emerging issues in COVID-19 epidemiology
    Jamie M. Caldwell, Xuan Le, Lorin McIntosh, Michael T. Meehan, Samson T. Ogunlade, Romain R. Ragonnet, Genevieve K. O’Neill, James McCracken Trauer, Emma Sue McBryde · 2021 · Paediatric Respiratory Reviews
22. Viral Load in COVID-19 Patients: Implications for Prognosis and Vaccine Efficacy in the Context of Emerging SARS-CoV-2 Variants
    Severino Jefferson Ribeiro da Silva, Suelen Cristina de Lima, Ronaldo Celerino da Silva, Alain Kohl, Lindomar Pena · 2022 · Frontiers in Medicine
23. Initial analysis of viral dynamics and circulating viral variants during the mRNA-1273 Phase 3 COVE trial
    Rolando Pajón, Yamuna Devi Paila, Bethany Girard, Groves Dixon, Katherine A. Kacena, Lindsey Robert Baden, Hana M. El Sahly, Brandon J. Essink, Kathleen M. Mullane, Ian Frank et al. · 2022 · Nature Medicine
24. Spike-antibody responses to ChAdOx1 and BNT162b2 vaccines by demographic and clinical factors (Virus Watch study)
    Madhumita Shrotri, Ellen Fragaszy, Cyril Geismar, Vincent Grigori Nguyen, Sarah Beale, Isobel Braithwaite, Thomas Byrne, Wing Lam Erica Fong, Jana Kovar, Annalan M D Navaratnam et al. · 2021 · medRxiv
25. Incorporating temporal distribution of population-level viral load enables real-time estimation of COVID-19 transmission
    Yun Lin, Bingyi Yang, Sarah E. Cobey, Eric H. Y. Lau, Dillon Charles Adam, Jessica Y. Wong, Helen S. Bond, Justin K. Cheung, Faith C. S. Ho, Huizhi Gao et al. · 2022 · Nature Communications
26. Surveillance of SARS-CoV-2 in sewage from buildings housing residents with different vulnerability levels
    Anna Pico-Tomàs, Cristina Mejías-Molina, Ian Zammit, Marta Rusiñol, Sílvia Bofill-Mas, Carles Borrego, Lluís Corominas · 2023 · The Science of The Total Environment
27. Prioritizing pregnant women for COVID‐19 vaccination
    Yamini Sarwal, Tanvi Sarwal, Rakesh Sarwal · 2021 · International Journal of Gynecology & Obstetrics
28. COVID-19 vaccine mandate for healthcare workers in the United States: a social justice policy
    Kobina Hagan, Rebecca Forman, Elias A. Mossialos, Paul Ndebele, Adnan Ali Hyder, Khurram Nasir · 2021 · Expert Review of Vaccines
29. Immunogenicity, efficacy and safety of COVID-19 vaccines: an update of data published by 31 December 2021
    Kun Xu, Chunxiang Fan, Yuxuan Han, Lianpan Dai, George F. Gao · 2022 · International Immunology
30. Effectiveness of COVID‑19 vaccines and their challenges (Review)
    Gabriella Marfè, Stefania Perna, Arvind Kumar Shukla · 2021 · Experimental and Therapeutic Medicine
31. COVID-19 Breakthrough Infections and Transmission Risk: Real-World Data Analyses from Germany’s Largest Public Health Department (Cologne)
    Lea Hsu, Barbara Grüne, Michael Buess, Christine Joisten, Jan Klobucnik, Johannes Nießen, David Patten, Anna Wolff, Gerhard Andreas Wiesmüller, Annelene Kossow et al. · 2021 · Vaccines
32. Multisociety statement on coronavirus disease 2019 (COVID-19) vaccination as a condition of employment for healthcare personnel
    David Jay Weber, Jaffar A. Al‐Tawfiq, Hilary M. Babcock, Kristina A. Bryant, Marci L. Drees, Ramy H. Elshaboury, Katharine Essick, Mohamad G. Fakih, David K. Henderson, Waleed Javaid et al. · 2021 · Infection Control and Hospital Epidemiology
33. Echinacea Purpurea For the Long-Term Prevention of Viral Respiratory Tract Infections During Covid-19 Pandemic: A Randomized, Open, Controlled, Exploratory Clinical Study
    Emil Kolev, Lilyana Mircheva, Michael R. Edwards, Sebastian Lennox Johnston, Krassimir Kalinov, Rainer Stange, Giuseppe Gancitano, Wim Vanden Berghe, Samo Kreft · 2022 · Frontiers in Pharmacology
34. Who Doesn't Want to Be Vaccinated? Determinants of Vaccine Hesitancy During COVID-19
    Era Dabla‐Norris, Hibah Khan, Frederico Lima, Alexandre B. Sollaci · 2021 · IMF Working Paper
35. Tafenoquine and its derivatives as inhibitors for the severe acute respiratory syndrome coronavirus 2
    Yeh Chen, Wenhao Yang, Hsiao‐Fan Chen, Li‐Min Huang, Jing-Yan Gao, Cheng‐Wen Lin, Yu-Chuan Wang, Chia‐Shin Yang, Yiliang Liu, Mei‐Hui Hou et al. · 2022 · Journal of Biological Chemistry
36. Quantitative modeling of the impact of facemasks and associated leakage on the airborne transmission of SARS-CoV-2
    Jean Schmitt, Jing Wang · 2021 · Scientific Reports
37. Safety and Immunogenicity Analysis of a Newcastle Disease Virus (NDV-HXP-S) Expressing the Spike Protein of SARS-CoV-2 in Sprague Dawley Rats
    J. Tcheou, A. Raskin, Gagandeep Singh, Hisaaki Kawabata, D. Bielak, Wei-Na Sun, Irene González-Domínguez, D. Sather, A. García-Sastre, P. Palese et al. · 2021 · Frontiers in Immunology
38. Payments and freedoms: Effects of monetary and legal incentives on COVID-19 vaccination intentions in Germany
    Philipp Sprengholz, Luca Henkel, Cornelia Betsch · 2022 · PLoS ONE
39. Decontamination of SARS-CoV-2 from cold-chain food packaging provides no marginal benefit in risk reduction to food workers
    Julia Silva Sobolik, Elizabeth T. Sajewski, Lee‐Ann Jaykus, D. Kane Cooper, Benjamin Alan Lopman, Alicia N.M. Kraay, Peter Barry Ryan, Jodie L. Guest, Amy Webb Girard, Juan S. León · 2021 · Food Control
40. Modelling direct and herd protection effects of vaccination against the SARS‐CoV‐2 Delta variant in Australia
    Emma Sue McBryde, Michael T. Meehan, Jamie M. Caldwell, Adeshina Israel Adekunle, Samson T. Ogunlade, Md Abdul Kuddus, Romain R. Ragonnet, Pavithra Jayasundara, James McCracken Trauer, Robert C. Cope · 2021 · The Medical Journal of Australia
41. Drug repurposing for the treatment of COVID-19
    Yuri Kato, Kazuhiro Nishiyama, Akiyuki Nishimura, Takamasa Noda, Kaori Okabe, Takahiro Kusakabe, Yasunari Kanda, Motohiro Nishida · 2022 · Journal of Pharmacological Sciences
42. Assessing COVID-19 Prevention Strategies to Permit the Safe Opening of Residential Colleges in Fall 2021
    A. David Paltiel, Jason L. Schwartz · 2021 · Annals of Internal Medicine
43. Why Does the SARS-CoV-2 Delta VOC Spread So Rapidly? Universal Conditions for the Rapid Spread of Respiratory Viruses, Minimum Viral Loads for Viral Aerosol Generation, Effects of Vaccination on Viral Aerosol Generation, and Viral Aerosol Clouds
    Byung Uk Lee · 2021 · International Journal of Environmental Research and Public Health
44. Predictors of Severe Acute Respiratory Syndrome Coronavirus 2 Infection Following High-Risk Exposure
    Kristin L. Andrejko, Jake M. Pry, Jennifer F. Myers, John J. Openshaw, James Watt, Nozomi Birkett, Jennifer L. DeGuzman, Camilla M. Barbaduomo, Zheng Dong, Anna T. Fang et al. · 2021 · Clinical Infectious Diseases
45. Building-Level Detection Threshold of SARS-CoV-2 in Wastewater
    Nicole C. Rondeau, Oliver J. Rose, Ellen R. Alt, Lina A. Ariyan, Annabelle B. Elikan, Jenna Everard, Abigail R. Schreier, Maya E. Tessler, Grace H. Tulinsky, Janet R. Vo et al. · 2023 · Microbiology Spectrum
46. Performance Characteristics of the Abbott BinaxNOW SARS-CoV-2 Antigen Test in Comparison to Real-Time Reverse Transcriptase PCR and Viral Culture in Community Testing Sites during November 2020
    Olivia Almendares, Jessica L. Prince-Guerra, Leisha D. Nolen, Jayleen K. L. Gunn, Ariella P. Dale, Sean A. Buono, Molly Deutsch-Feldman, Suganthi Suppiah, LiJuan Hao, Yan Zeng et al. · 2021 · Journal of Clinical Microbiology
47. Counting on COVID-19 Vaccine: Insights into the Current Strategies, Progress and Future Challenges
    Ramesh J. L. Kandimalla, Pratik Chakraborty, Jayalakshmi Vallamkondu, Anupama Chaudhary, Sonalinandini Samanta, P. Hemachandra Reddy, Vincenzo De Feo, Saikat Dewanjee · 2021 · Biomedicines
48. Challenges of evaluating and modelling vaccination in emerging infectious diseases
    Zachary J. Madewell, Natalie E. Dean, Jesse A. Berlin, PAUL M. COPLAN, Kourtney J. Davis, Claudio José Struchiner, M. Elizabeth Halloran · 2021 · Epidemics
49. Interpreting estimates of coronavirus disease 2019 (COVID-19) vaccine efficacy and effectiveness to inform simulation studies of vaccine impact: a systematic review
    Natsuko Imai, Alexandra B. Hogan, Lucy R Williams, Anne Cori, Tara D. Mangal, Peter Winskill, Lilith K. Whittles, Oliver John Watson, Edward Knock, Marc Baguelin et al. · 2021 · Wellcome Open Research
50. The SwissCovid Digital Proximity Tracing App after one year: Were expectations fulfilled?
    Paola Daniore, Tala Ballouz, Dominik Menges, Viktor von Wyl · 2021 · Swiss Medical Weekly
51. Beyond the acute illness: Exploring long COVID and its impact on multiple organ systems
    Nandini Bhattacharjee, Parantap Sarkar, Tania Sarkar · 2023 · Physiology International
52. BNT162b2 mRNA Vaccine Effectiveness Given Confirmed Exposure: Analysis of Household Members of Coronavirus Disease 2019 Patients
    Gazit, Sivan, Mizrahi, Barak, Kalkstein, Nir, Neuberger, Ami, Peretz, Asaf, Mizrahi-Reuveni, Miri, Ben-Tov, Amir, Patalon, Tal · 2022 · Clinical Infectious Diseases
53. Agent-based simulations for protecting nursing homes with prevention and vaccination strategies
    Jana Lasser, Johannes A. Zuber, Johannes Sorger, Elma Dervić, Katharina Ledebur, Simon David Lindner, Elisabeth Klager, Maria Kletečka-Pulker, Harald Willschke, Katrin Stangl et al. · 2021 · Journal of The Royal Society Interface
54. Effect of COVID-19 vaccination on the SARS-CoV-2 transmission among social and household close contacts: A cohort study
    Iván Martínez‐Baz, Ana Miqueleiz, Nerea Egüés, Itziar Casado, Cristina Burgui, Aitziber Echeverría, Ana Navascués, Miguel Fernández-Huerta, Manuel Garcìa Cenoz, Camino Trobajo‐Sanmartín et al. · 2023 · Journal of Infection and Public Health
55. Mathematical Modeling of Vaccines That Prevent SARS-CoV-2 Transmission
    David A. Swan, Ashish Goyal, Chloe Bracis, Mia Moore, Elizabeth M. Krantz, Elizabeth R. Brown, Erwing Fabian Cardozo Ojeda, Daniel B. Reeves, Fei Gao, Peter B. Gilbert et al. · 2021 · Viruses
56. SARS-CoV-2 mRNA Vaccine Breakthrough Infections in Fully Vaccinated Healthcare Personnel: A Systematic Review
    Caterina Ledda, Claudio Costantino, Giuseppe Motta, Rosario Cunsolo, Patrizia Stracquadanio, Giuseppe Liberti, Helena C. Maltezou, Venerando Rapisarda · 2022 · Tropical Medicine and Infectious Disease
57. Appropriate relaxation of non-pharmaceutical interventions minimizes the risk of a resurgence in SARS-CoV-2 infections in spite of the Delta variant
    Wadim Koslow, Martin J. Kühn, Sebastian C. Binder, Margrit Klitz, Daniel Abele, Achim Basermann, Michael Meyer‐Hermann · 2022 · PLoS Computational Biology
58. mRNA vaccination drives differential mucosal neutralizing antibody profiles in naïve and SARS-CoV-2 previously-infected individuals
    Stéphanie Longet, Alexander Hargreaves, Saoirse Healy, Rebecca L. Brown, Hailey R. Hornsby, Naomi Meardon, Tom Tipton, Eleanor J. Barnes, Susanna Jane Dunachie, Christopher James Arthur Duncan et al. · 2022 · Frontiers in Immunology
59. Comparing COVID-19 vaccines for their characteristics, efficacy and effectiveness against SARS-CoV-2 and variants of concern
    Thibault Fiolet, Yousra Kherabi, Conor James MacDonald, Jade Ghosn, Nathan Peiffer‐Smadja · 2021
60. Breakthrough Infections with Multiple Lineages of SARS-CoV-2 Variants Reveals Continued Risk of Severe Disease in Immunosuppressed Patients
    Xufang Deng, Monika Evdokimova, Amornrat O’Brien, Cynthia L. Rowe, Nina M. Clark, Amanda Harrington, Gail Reid, Susan L. Uprichard, Susan C. Baker · 2021 · Viruses
61. Detection of SARS-CoV-2 infection in the general population by three prevailing rapid antigen tests: cross-sectional diagnostic accuracy study
    Roderick P Venekamp, Irene K Veldhuijzen, Karel G.M. Moons, Wouter van den Bijllaardt, Suzan D. Pas, Esther B Lodder, Richard Molenkamp, Zsὁfia Iglὁi, Constantijn Wijers, Claudy Oliveira dos Santos et al. · 2022 · BMC Medicine
62. Inferring the reproduction number using the renewal equation in heterogeneous epidemics
    William D. Green, Neil M. Ferguson, Anne Cori · 2022 · Journal of The Royal Society Interface
63. Quantifying the Population-Level Effect of the COVID-19 Mass Vaccination Campaign in Israel: A Modeling Study
    Ido Somekh, Wasiur R. KhudaBukhsh, Elisabeth Dowling Root, Lital Keinan‐Boker, Grzegorz A. Rempała, Eric A. F. Simões, Eli Somekh · 2022 · Open Forum Infectious Diseases
64. Vaccination reduces viral load and accelerates viral clearance in SARS-CoV-2 Delta variant-infected patients
    Hongxia Li, Yanzi Li, Junhui Liu, Jianlin Liu, Jianfeng Han, Lin Yang · 2023 · Annals of Medicine
65. Psychological reactance and vaccine uptake: a longitudinal study
    Iris Anna Maria Verpaalen, Simone M. Ritter, Madelon L. M. van Hooff, Aart van Stekelenburg, Marieke L. Fransen, Rob W. Holland · 2023 · Psychology and Health
66. Influenza Virus and SARS-CoV-2 Vaccines
    Adam Sandor, Michael S. Sturdivant, Jenny P.‐Y. Ting · 2021 · The Journal of Immunology
67. Mitigating SARS-CoV-2 Transmission in Hospitals: A Systematic Literature Review
    Chester Yan Hao Ng, Nicole-Ann Lim, Lena X. Y. Bao, Amy M.L. Quek, Raymond C.S. Seet · 2022 · Public health reviews
68. Clinical and Molecular Relationships between COVID-19 and Feline Infectious Peritonitis (FIP)
    Arjun Sweet, Nicole M. André, Alison E. Stout, Beth Nicole Licitra, Gary R. Whittaker · 2022 · Viruses
69. COVID-19 Exposure Assessment Tool (CEAT): Exposure quantification based on ventilation, infection prevalence, group characteristics, and behavior
    Brian J. Schimmoller, Nídia Sequeira Trovão, Molly Isbell, Chirag Goel, Benjamin F. Heck, Tenley C. Archer, Klint D. Cardinal, Neil B. Naik, Som Dutta, A.D. Rohr et al. · 2022 · Science Advances
70. A 2-month field cohort study of SARS-CoV-2 in saliva of BNT162b2 vaccinated nursing home workers
    Claude Saegerman, Anh Nguyet Diep, Véronique Renault, Anne‐Françoise Donneau, Lambert Stamatakis, Wouter R. Coppieters, Fabienne Michel, Christophe Breuer, Margaux Dandoy, Olivier Ek et al. · 2022 · Communications Medicine
71. Seroprevalence of SARS-CoV-2 Antibodies in Adults and Healthcare Workers in Southern Italy
    Francesco Napolitano, Gabriella Di Giuseppe, Maria Vittoriå Montemurro, Anna Maria Molinari, Giovanna Donnarumma, Antonio Arnese, María Pavía, Italo Francesco Angelillo · 2021 · International Journal of Environmental Research and Public Health
72. Evaluation of protection by COVID-19 vaccines after deployment in low and lower-middle income countries
    John David Clemens, Asma Binte Aziz, Birkneh Tilahun Tadesse, Sophie Suh Young Kang, Florian Marks, Jérôme H. Kim · 2021 · EClinicalMedicine
73. Protect ya Grandma! The Effects of Students' Epistemic Beliefs and Prosocial Values on COVID-19 Vaccination Intentions
    Tom Rosman, Kathrin Adler, Luisa Barbian, Vanessa Blume, Benno Burczeck, Vivien Cordes, Dilara Derman, Susanne Dertli, Hannah Glas, Virginia Heinen et al. · 2021 · Frontiers in Psychology
74. Estimating Vaccine Efficacy Against Transmission via Effect on Viral Load
    Lee Kennedy‐Shaffer, Rebecca J. Kahn, Marc Lipsitch · 2021 · Epidemiology
75. Vaccination against COVID-19 and society’s return to normality in England: a modelling study of impacts of different types of naturally acquired and vaccine-induced immunity
    Fujian Song, Max Oscar Bachmann · 2021 · BMJ Open
76. Original Hosts, Clinical Features, Transmission Routes, and Vaccine Development for Coronavirus Disease (COVID-19)
    Ting Wu, Shuntong Kang, Wenyao Peng, Chenzhe Zuo, Yuhao Zhu, Liangyu Pan, Keyun Fu, Yaxian You, Xinyuan Yang, Xuan Luo et al. · 2021 · Frontiers in Medicine
77. Effectiveness of BNT162b2 mRNA COVID-19 Vaccine Against Acquisitions of SARS-CoV-2 Among Health Care Workers in Long-Term Care Facilities: A Prospective Cohort Study
    Khitam Muhsen, Nimrod Maimon, Ami Mizrahi, Omri Bodenheimer, Dani Cohen, Michal S. Maimon, Itamar Grotto, Ron Dagan · 2021 · Clinical Infectious Diseases
78. Sociodemographic Disparities In Access To COVID-19 Vaccines Upon Initial Rollout In Florida
    Jennifer M. Attonito, Whitney Van Arsdale, Keren Fishman, Maral Darya, Mario Jacomino, George R. Luck · 2021 · Health Affairs
79. Building a Better Silver Bullet: Current Status and Perspectives of Non‐Viral Vectors for mRNA Vaccines
    Jiayu Gu, Zhourui Xu, Qiqi Liu, Shiqi Tang, Wenguang Zhang, Shouxia Xie, Xiaoyan Chen, Jiajie Chen, Ken‐Tye Yong, Chengbin Yang et al. · 2023 · Advanced Healthcare Materials
80. SARS-CoV-2 RT-qPCR Test Detection Rates Are Associated with Patient Age, Sex, and Time since Diagnosis
    Matan Levine-Tiefenbrun, Idan Yelin, Hedva Uriel, Jacob Kuint, Licita Schreiber, Esma Herzel, Rachel Katz, Amir Ben‐Tov, Sivan Gazit, Tal Patalon et al. · 2021 · Journal of Molecular Diagnostics
81. An update on host immunity correlates and prospects of re-infection in COVID-19
    Neema Negi, Shesh Prakash Maurya, Ravinder Singh, Bimal Kumar Das · 2021 · International Reviews of Immunology
82. Considerations regarding Interpretation of Positive SARS-CoV-2 Molecular Results with Late Cycle Threshold Values
    Stephanie L. Mitchell, Michael J. Loeffelholz · 2022 · Journal of Clinical Microbiology
83. Early effectiveness of BNT162b2 Covid-19 vaccine in preventing SARS-CoV-2 infection in healthcare personnel in six Israeli hospitals (CoVEHPI)
    Mark A. Katz, Efrat Bron‐Harlev, Bibiana Chazan, Michal Chowers, David Greenberg, Alon Peretz, Sagi Tshori, Joseph Levy, Mili Yacobi, Avital Hirsch et al. · 2021 · Vaccine
84. Prioritizing high-contact occupations raises effectiveness of vaccination campaigns
    Hendrik Nunner, Arnout van de Rijt, Vincent Buskens · 2022 · Scientific Reports
85. The social gradient in COVID-19 vaccination intentions and the role of solidarity beliefs among adolescents
    Alexander Patzina, Hans W. Dietrich · 2022 · SSM - Population Health
86. SARS-CoV-2 infections in mRNA vaccinated individuals are biased for viruses encoding spike E484K and associated with reduced infectious virus loads that correlate with respiratory antiviral IgG levels
    Heba H. Mostafa, Chun Huai Luo, C. Paul Morris, Maggie Li, Nicholas J. Swanson, Adannaya Amadi, Nicholas Gallagher, Andrew S Pekosz · 2022 · Journal of Clinical Virology
87. Detection of SARS-CoV-2 and Other Viruses in Wastewater: Optimization and Automation of an Aluminum Hydroxide Adsorption–Precipitation Method for Virus Concentration
    Lina Yu, Zhe Tian, Dev Raj Joshi, Lin Yuan, Reshma Tuladhar, Yu Zhang, Min Yang · 2022 · ACS ES&T Water
88. Association between SARS-CoV-2 Viral Load and Patient Symptoms and Clinical Outcomes Using Droplet Digital PCR
    Elizabeth Hastie, Harold Amogan, David J. Looney, Sanjay R. Mehta · 2023 · Viruses
89. AKT activity orchestrates marginal zone B cell development in mice and humans
    Eva-Maria Cox, Mohamed El Behi, Stefanie Ries, Johannes F. Vogt, Vivien Kohlhaas, Thomas Michna, Benoît Manfroi, Mona Al-Maarri, Florian Wanke, Boaz Tirosh et al. · 2023 · Cell Reports
90. Outpatient Treatment of SARS-CoV-2 Infection to Prevent COVID-19 Progression
    M. Cohen, D. Wohl, William A. Fischer, David Smith, J. Eron · 2021 · Clinical Infectious Diseases
91. SARS-CoV-2 Surveillance in Belgian Wastewaters
    Raphaël Janssens, Sven Hanoteaux, Hadrien Maloux, Sofieke Klamer, Valeska Laisnez, Bavo Verhaegen, Catherine Linard, Lies Lahousse, Peter Delputte, Matthieu Terwagne et al. · 2022 · Viruses
92. Effectiveness of BNT162b2 and ChAdOx1 against SARS-CoV-2 household transmission: a prospective cohort study in England
    Samuel Clifford, Pauline Waight, Jada Hackman, Stéphane Hué, Charlotte Gower, Freja Cordelia Møller Kirsebom, Catriona Skarnes, Louise H Letley, Jamie Lopez Bernal, Nick J Andrews et al. · 2023 · Wellcome Open Research
93. Controlling risk of SARS-CoV-2 infection in essential workers of enclosed food manufacturing facilities
    Julia Silva Sobolik, Elizabeth T. Sajewski, Lee‐Ann Jaykus, D. Kane Cooper, Benjamin Alan Lopman, Alicia N.M. Kraay, Peter Barry Ryan, Juan S. León · 2021 · Food Control
94. The impact of vaccination and SARS-CoV-2 variants on the virological response to SARS-CoV-2 infections during the Alpha, Delta, and Omicron waves in England
    Rachel Lunt, Catherine Quinot, Freja Cordelia Møller Kirsebom, Nick J Andrews, Catriona Skarnes, Louise H Letley, Donna Haskins, Catriona Angel, Skye Firminger, Kay Ratcliffe et al. · 2023 · Journal of Infection
95. The March 2021 Thessaly earthquakes and their impact through the prism of a multi-hazard approach in disaster management
    Spyridon D. Mavroulis, Maria D. Mavrouli, Panayotis Carydis, Κωνσταντίνος Αγοραστός, Efthymis Lekkas · 2021 · Bulletin of the Geological Society of Greece
96. Fundamental limitations of contact tracing for COVID-19
    Paul F. Tupper, Sarah Perin Otto, Caroline Colijn · 2021 · FACETS
97. SARS-CoV-2 Delta Variant in Jingmen City, Hubei Province, China, 2021: Children Susceptible and Vaccination Breakthrough Infection
    Dan Li, Ai-e Li, Zhu-qing Li, Yu Bao, Tian Liu, Xiang‐Rong Qin, Xue‐jie Yu · 2022 · Frontiers in Microbiology
98. Comparative performance and cycle threshold values of 10 nucleic acid amplification tests for SARS-CoV-2 on clinical samples
    Miyuki Mizoguchi, Sohei Harada, Koh Okamoto, Yoshimi Higurashi, Mahoko Ikeda, Kyoji Moriya · 2021 · PLoS ONE
99. Immunology of SARS-CoV-2 infections and vaccines
    Dominik Schenten, Deepta Bhattacharya · 2021 · Advances in immunology
100. SARS-CoV-2: Overview and Its Impact on Oral Health
     Miriam Ting, Jon B. Suzuki · 2021 · Biomedicines